Ingrid Caras's Biography

Ingrid Caras, Senior Science Officer, California Institute for Regenerative Medicine

Dr. Ingrid Caras is a Senior Science Officer at the California Institute for Regenerative Medicine (CIRM) where she is involved in developing and implementing CIRM’s scientific programs. Prior to joining CIRM in September, 2009, she held the positions of Executive Director of Preclinical and Clinical Development Sciences and Senior Director of Bioanalytical Sciences at PDL Biopharma, where she oversaw a multi-functional department responsible for preclinical development of therapeutic antibodies and for the non-clinical portions of early clinical trials. In this role, she participated in strategy development for development programs in oncology and immunology and contributed to multiple IND filings and early clinical trials.

Before joining PDL Biopharma in 2003, Dr. Caras spent 5-years as Director of Cell Biology and Development Sciences at Eos Biotechnology, and 14-years at Genentech, initially as a Scientist and later as a Senior Scientist. Dr. Caras has extensive experience in both basic research as well as drug development and has worked in a number of diverse areas that include immunology, cell and molecular biology, cancer and neuroscience. She was principal consultant at IWC Bioscience and provided consulting services to the pharmaceutical industry, particularly in the area of immunogenicity of biologics.

Dr. Caras earned a B.Sc (Hons) degree from the University of the Witwatersrand in Johannesburg, South Africa and a Ph.D. from the Hebrew University of Jerusalem in Israel. She did post-doctoral training at Harvard University and at the University of California, San Francisco.